Nanologica AB

NICA · Nasdaq Stockholm · Healthcare

0.31SEK +2.0%last day

Price as of 2 October 2026

The price over the past year, with dividends: −73.2%

Performance

1 month

−14.9%

1 year

−73.2%

3 years, per year

−68.6%

5 years, per year

−53.7%

Largest fall, 3 years

−97.3%

Below the peak now

−98.8%

Volatility, 1 year

142.3%

Return with dividends reinvested.

Key figures

P/E

4.7

P/B

0.6

Dividend yield

0.0%

Return on equity

+12.0%

Net margin

+34.9%

Market value

9 m USD

Quality, value and trend

Where Nanologica stands against every Nordic stock today. 100 is best.

Quality88

Profitability and a sound balance sheet over time. Better than 88% of Nordic stocks.

Value95

The price measured against earnings, assets and cash flow. Better than 95% of Nordic stocks.

Trend6

The price development over the past year. Better than 6% of Nordic stocks.

Combined74

Quality, value and trend together. Better than 74% of Nordic stocks.

About Nanologica

Nanologica AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 72 employees.

Nanologica AB (publ), a life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally. The company offers NLAB Saga, a silica-based purification media for preparative chromatography that is developed for the purification of peptide drugs, such as insulin and GLP-1 analogues; NLAB Idun, an ion exchange product for robust, reproducible, and efficient downstream purification of GLP-1 analogues and other peptides; NLAB Idun SP, a strong cation exchanger with sulfopropyl groups as ligands; NLAB Idun Q, a strong anion exchanger with a quaternary amine ligand; and NLAB Siv, a non-silica-based media for purif…

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis